(Finance) – Valtecnea company listed on Euronext Growth Milan which operates in the sector of high precision mechanics for medical devices and industrial applications, has closed its first nine months of 2024 with sales revenue equal to 24 million euros, up 0.5% compared to the same period of the previous year (equal to 23.8 million).
The Business line Medical marks a +17.9% to 16.6 million euros, while the Business line Industrial a -24.5% to 7.4 million euros.
“The results recorded in the first nine months of 2024 confirm the effectiveness of our strategy focused on the medical sector, which continued to grow solidly and constantly, with an increase of +17.9% – commented theCEO Paolo Mainetti – This positive trend has allowed the medical business line to now represent almost 70% of our overall turnover. We continue to strengthen our presence in this market, adopting a targeted and selective approach, while optimizing management in the industrial sector, which continues to be affected by the difficulties linked to the European macroeconomic context.”